相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count
Andreas Weiss et al.
ANALYTICAL BIOCHEMISTRY (2011)
Oligonucleotide therapeutic approaches for Huntington disease
Dinah W. Y. Sah et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease
John Labbadia et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Hsp70 and Its Molecular Role in Nervous System Diseases
Giuseppina Turturici et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2011)
Co-chaperones are limiting in a depleted chaperone network
Lonneke Heldens et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle
Gregor P. Lotz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Acute Polyglutamine Expression in Inducible Mouse Model Unravels Ubiquitin/Proteasome System Impairment and Permanent Recovery Attributable to Aggregate Formation
Zaira Ortega et al.
JOURNAL OF NEUROSCIENCE (2010)
Heat shock protein 90 in neurodegenerative diseases
Wenjie Luo et al.
MOLECULAR NEURODEGENERATION (2010)
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Mikko Taipale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington's disease
Andreas Weiss et al.
ANALYTICAL BIOCHEMISTRY (2009)
Development of a Method for the High-Throughput Quantification of Cellular Proteins
Paolo Paganetti et al.
CHEMBIOCHEM (2009)
Small molecule drug discovery for Huntington's Disease
Wolfgang Fecke et al.
DRUG DISCOVERY TODAY (2009)
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse
Keisuke Tokui et al.
HUMAN MOLECULAR GENETICS (2009)
Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease
Jennifer L. Wacker et al.
JOURNAL OF NEUROSCIENCE (2009)
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
Andreas Weiss et al.
MOLECULAR NEURODEGENERATION (2009)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The ground state of embryonic stem cell self-renewal
Qi-Long Ying et al.
NATURE (2008)
Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
Jodi L. McBride et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease
Jesse M. Hunter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells
Miriam Bibel et al.
NATURE PROTOCOLS (2007)
Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction
Monzy Thomas et al.
HUMAN MOLECULAR GENETICS (2006)
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG gamma as a therapeutic target
JS Bett et al.
HUMAN MOLECULAR GENETICS (2006)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation
AB Bowman et al.
HUMAN MOLECULAR GENETICS (2005)
Development and implementation of a highly miniaturized confocal 2D-FIDA-based high-throughput screening assay to search for active site modulators of the human heat shock protein 90β
A Schilb et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery
WB Pratt et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Neuronal cells show regulatory differences in the hsp70 gene response
K Kaarniranta et al.
MOLECULAR BRAIN RESEARCH (2002)
New anti-huntingtin monoclonal antibodies: Implications for huntingtin conformation and its binding proteins
J Ko et al.
BRAIN RESEARCH BULLETIN (2001)
Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice
CJ Cummings et al.
HUMAN MOLECULAR GENETICS (2001)
Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease
A Sittler et al.
HUMAN MOLECULAR GENETICS (2001)
Neurological abnormalities in a knock-in mouse model of Huntington's disease
CH Lin et al.
HUMAN MOLECULAR GENETICS (2001)
Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
PJ Muchowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
A Yamamoto et al.
CELL (2000)